The U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with ...

The US Food and Drug Administration has approved VYALEV, a groundbreaking therapy developed by AbbVie to treat adults with ...

Neurologist Jason Aldred helped conduct trials for the device in Spokane through his work at Selkirk Neurology, where he ...

Vyalev, also known as Produodopa, has been approved in 35 countries, with more than 4200 patients having started treatment.

Brain disorders like Parkinson's disease (PD) or Alzheimer's disease (AD ... "Research on EVs in our and other groups over ...

Brain disorders like Parkinson’s or Alzheimer’s Disease start to develop in patients much earlier than when their first ...

Advancements in organoid technology are crucial for Parkinson's disease research, providing human-relevant models for ...

BENGALURU: Parkinson’s disease (PD) has no cure, and the symptoms get worse as the disease progresses with the patient age.

Delphi-MD employs direct electrophysiological imaging technology to provide real-time insights into brain network function.

Knowledge on the genetic basis of Parkinson's disease has grown tremendously since the discovery of the first monogenic form, ...

Anew study has investigated how exposure to antimicrobials influences the risk of Parkinson's <a target=_blank href= ...